IMMUTOL
ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES
| Grant period | 2023-05-01 - 2027-04-30 |
| Funding body | European Union |
| Call number | HORIZON-HLTH-2022-DISEASE-06-two-stage |
| Grant number | 101080562 |
| Identifier | G:(EU-Grant)101080562 |